Tagged with CR-CP Life Science Fund

Da Liu – Managing Director, CR-CP Life Science Fund

Hong Kong Da Liu – Managing Director, CR-CP Life Science Fund

Hong Kong As managing director of the CR-CP Life Science Fund, whose shareholders, CR Group and CP Group, are on the Fortune Global 500 List, Da Liu leads investments in life sciences companies globally, especially those in emerging sectors such as RNA therapeutics and cancer screening. In conversation with PharmaBoardroom, Liu discusses…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here